News

Immorta Bio Showcases Innovative SenoVax™ at Key Symposium

Immorta Bio Showcases Innovative SenoVax™ at Key Symposium

Immorta Bio's Revolutionary SenoVax™ Presentation

Immorta Bio is set to unveil promising results related to its groundbreaking SenoVax™ product at an esteemed symposium dedicated to the advancement of cancer immunotherapy. The poster presentation will spotlight the success achieved in experiments targeting lung, breast, pancreatic, and brain cancers.

Overview of SenoVax™

SenoVax™, a unique senolytic immunotherapy, is designed to selectively eliminate senescent cells that are implicated in cancer development and progression. Dr. Thomas Ichim, President and Chief Scientific Officer of Immorta Bio, emphasized the significance of their research, stating, "We will share compelling data showing cancer regression in animal models with glioma, lung, breast, and pancreatic cancers utilizing our innovative SenoVax approach.”

The Upcoming Symposium

The Society for Immunotherapy of Cancer (SITC) symposium will be held in San Diego, showcasing cutting-edge research aimed at transforming cancer treatment. Immorta Bio's participation underscores the importance of their findings, particularly how targeting senescent cells can change the paradigm of cancer therapy.

Collaboration with leading institutions including the University of California San Diego and George Washington University has been pivotal in the development and validation of SenoVax™. This work positions Immorta Bio at the forefront of cancer research.

Statements from Leadership

Dr. Boris Reznik, Chairman and CEO of Immorta Bio, expressed his enthusiasm for the opportunity to present at the symposium. He noted, "Being chosen to present to such a distinguished audience speaks volumes about the potential of our paradigm-shifting approach. By targeting senescent cells, we are not just addressing cancer but also potentially reducing the overall burden of cellular senescence, which may provide anti-aging benefits to treated patients.”

About Immorta Bio

Immorta Bio Inc. is a pioneering scientific longevity company that focuses on addressing aging-related diseases through innovative technologies. Their mission, encapsulated in their motto “Treating Diseases of Aging and Treating Aging as Disease™,” aims to tackle significant medical challenges posed by advanced cancers and age-associated conditions. For more information about Immorta Bio’s initiatives and research efforts, visit their official website.

Company Contact

For inquiries, please contact Dr. Boris Reznik at Immorta Bio through their official site. You can also connect with them via social media for the latest updates on their research and developments.

Frequently Asked Questions

What is SenoVax™?

SenoVax™ is a first-in-class senolytic immunotherapy that targets and eliminates senescent cells associated with cancer.

Where will the presentation take place?

The presentation will be at the Society for Immunotherapy of Cancer symposium in San Diego.

What types of cancers are being studied with SenoVax™?

The studies focus on lung, breast, pancreatic, and brain cancers.

Who is leading the research at Immorta Bio?

The research is led by Dr. Thomas Ichim and overseen by Dr. Boris Reznik.

What is the goal of Immorta Bio?

Immorta Bio aims to treat age-related diseases and improve longevity through innovative therapeutic approaches.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Dar Global Eyes Dubai for Strategic Real Estate Moves

Updated Category News Views 0

Tapping into Dubai's Real Estate Allure Every seasoned investor knows the real estate game ain't for the faint of heart, especially when you’re playing in a market as competitive as Dubai's. But here comes Dar Global Capital Partners (DGCP), throwing their hat into the ring with a fresh strategy centered around high-value real estate. Sure, they aren't new to the...

Continue Reading
OncoHost's Research Links TKI Sensitivity to Biology

Updated Category News Views 49

Cracking the Code on TKI Sensitivity When it comes to medicine, sometimes the trickiest part is knowing which button to push—especially in the high-stakes world of metastatic renal cell carcinoma (mRCC). OncoHost just dropped a bombshell at the ESMO 2026 Congress about their new plasma proteomics model that lets us peer into what makes some patients click with Tyrosine...

Continue Reading
HONOR X9e Pro Unveils with Massive Battery Power

Updated Category News Views 0

Lighting Up the Sky: HONOR's Big Move Picture this: the Burj Khalifa in Dubai, world’s tallest building, flashing with the promise of a smartphone's monstrous battery. That’s what the fine folks at HONOR did, highlighting their X9e Pro and its mind-boggling 11,000mAh battery. Now, am I the only one who finds it more than a little audacious to leverage such a flashy...

Continue Reading
Vantrue's Black Friday Dash Cam Deals: Save up to 44%

Updated Category News Views 195

Kicking Off Early Black Friday with Dash Cam Bargains In a bid to stay ahead of the holiday shopping rush, Vantrue announced its early Black Friday campaign with a range of discounts designed to capture the interest of road warriors and casual drivers alike. From November 1 to November 21, 2026, Vantrue is inviting bargain hunters to explore their offerings—culminating...

Continue Reading
Sac-TMT's Phase III Success Shifts Lung Cancer Paradigm

Updated Category News Views 606

A New Era in Lung Cancer Treatment? Sac-TMT, the novel antibody-drug conjugate (ADC), just might be shaking up the non-small cell lung cancer (NSCLC) treatment landscape, and boy, is it making waves. Just when you think you’ve seen it all, here comes sacituzumab tirumotecan (sac-TMT), offering a glimmer of hope for patients whose treatment options have dwindled after...

Continue Reading
Dr. Boonipat Inspires Future Women Surgeons at Texas Tech

Updated Category News Views 294

Sowing Surgical Seeds in Lubbock In Lubbock, Texas, something meaningful unfolded—an event the big market players would hardly blink at, but a significant step for the future of medicine. Led by Dr. Thanapoom "Mo" Boonipat, the founder of FacePlus Plastic Surgery Institute, a unique suturing workshop provided premed students at Texas Tech University hands-on experience...

Continue Reading
Sirha Lyon® 2027: A New Chapter in Foodservice

Updated Category News Views 0

A Bold Step Forward There's a hearty aroma wafting from Lyon this January, and it's not just from the local gastronomy. Sirha Lyon® is queuing up for its 23rd edition, promising to turn the Foodservice and Hospitality sectors on their heads. Nearly 150,000 square meters of exhibition space packed to the rafters with over 4,300 exhibitors—this ain't your average trade...

Continue Reading
Gildan Activewear Faces Legal Battle Over Alleged Fraud

Updated Category News Views 205

Investor Alert: Gildan's Legal Showdown Alright, here's a twist you didn't see coming—or maybe you did if you've been tracking the ticker tapes like a hawk. Gildan Activewear Inc. (NYSE:GIL) is stuck in the kind of hot water that can scald the bottom line. The Stakes: Racing Towards December 14 Marked on your calendar, December 14, is a date of some significance if...

Continue Reading
Love Business Group Helps SMEs Navigate Broadband Choices

Updated Category News Views 215

Understanding Broadband Needs for UK SMEs When you're knee-deep in running a small biz in the UK, sorting out your broadband needs can feel like sifting through a thousand-piece puzzle. Enter Love Business Group, getting a nod of recognition for being the SME knight in shining armor. Aimed at businesses of all sizes, they've been pegged by Expert Consumers for helping...

Continue Reading
Elbit Systems Lands $200M APAC ISTAR Contracts

Updated Category News Views 21

Elbit Systems Secures Major Asia-Pacific Deal You know, it's not every day that a defense contractor like Elbit Systems (NASDAQ:ESLT) bags a $200 million deal in the Asia-Pacific region. A big move in a high-stakes game where technology, strategy, and geography collide. This isn't some random supply deal; this involves the cutting edge of defense tech—ISTAR and training...

Continue Reading

Top 5 Most Recently Viewed Articles

KuCoin Partners with Tomorrowland to Revolutionize Festivals

Updated Category News Views 99

KuCoin Collaborates with Tomorrowland for Unique Festival Experiences Partnership Bridges Culture and Technology to Empower the People of Tomorrow KuCoin, a leading global cryptocurrency platform, has forged a multi-year partnership with Tomorrowland Winter and Tomorrowland Belgium, establishing itself as the Exclusive Crypto Exchange and Payments Partner for these...

Continue Reading
Uber's Cash Payment Policy Raises Safety Concerns for Drivers

Updated Category News Views 301

Uber Drivers Voice Safety Worries Following Cash Payment Introduction Drivers collaborating with Uber Technologies Inc. UBER are raising significant concerns as the popular ride-hailing service officially accepts cash payments for rides. This move has sparked worries about potential safety risks for drivers who now might become targets for theft. Concerns of Targeted...

Continue Reading
Klarna Makes a Grand Return to the Stock Market Arena

Updated Category News Views 246

Klarna's Remarkable IPO Journey Buy-now, pay-later firm Klarna has successfully raised $1.37 billion in its U.S. initial public offering. The firm priced its shares at $40, surpassing the expected range of $35 to $37, marking a notable return to the public market. This significant debut opens up new possibilities for the fintech sector and could signal the start of...

Continue Reading
Startek Philippines Achieves Distinction at Leadership Awards

Updated Category News Views 257

Startek Philippines Recognized for Excellence in Leadership Startek, a leading global provider of customer experience (CX) solutions, proudly announced that Startek Philippines has received four notable honors at The Philippines Leadership Awards 2025. These prestigious awards, presented by the World HRD Congress, celebrate organizations that excel in innovative...

Continue Reading
DeFi Technologies Reports Strong Financial Performance in 2024

Updated Category News Views 368

Increasing Revenue and Achievements in 2024 DeFi Technologies Inc. is thrilled to share its remarkable financial outcomes for the year 2024, showcasing a strong growth trajectory. The company achieved adjusted revenues of C$204.4 million (approximately US$144.8 million), with adjusted EBITDA recorded at C$116.1 million (US$80.4 million) and adjusted net income totaling...

Continue Reading